146 related articles for article (PubMed ID: 31334877)
1. Glucocorticoid receptor upregulation increases radioresistance and triggers androgen independence of prostate cancer.
Chen X; Chen F; Ren Y; Weng G; Keng PC; Chen Y; Lee SO
Prostate; 2019 Sep; 79(12):1386-1398. PubMed ID: 31334877
[TBL] [Abstract][Full Text] [Related]
2. Radiation-induced glucocorticoid receptor promotes CD44+ prostate cancer stem cell growth through activation of SGK1-Wnt/β-catenin signaling.
Chen F; Chen X; Ren Y; Weng G; Keng PC; Chen Y; Lee SO
J Mol Med (Berl); 2019 Aug; 97(8):1169-1182. PubMed ID: 31187175
[TBL] [Abstract][Full Text] [Related]
3. The expression of glucocorticoid receptor is negatively regulated by active androgen receptor signaling in prostate tumors.
Xie N; Cheng H; Lin D; Liu L; Yang O; Jia L; Fazli L; Gleave ME; Wang Y; Rennie P; Dong X
Int J Cancer; 2015 Feb; 136(4):E27-38. PubMed ID: 25138562
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer.
Isikbay M; Otto K; Kregel S; Kach J; Cai Y; Vander Griend DJ; Conzen SD; Szmulewitz RZ
Horm Cancer; 2014 Apr; 5(2):72-89. PubMed ID: 24615402
[TBL] [Abstract][Full Text] [Related]
5. The Dual Androgen Receptor and Glucocorticoid Receptor Antagonist CB-03-10 as Potential Treatment for Tumors that have Acquired GR-mediated Resistance to AR Blockade.
Rosette C; Agan FJ; Rosette N; Mazzetti A; Moro L; Gerloni M
Mol Cancer Ther; 2020 Nov; 19(11):2256-2266. PubMed ID: 32847976
[TBL] [Abstract][Full Text] [Related]
6. SIRT7 depletion inhibits cell proliferation and androgen-induced autophagy by suppressing the AR signaling in prostate cancer.
Ding M; Jiang CY; Zhang Y; Zhao J; Han BM; Xia SJ
J Exp Clin Cancer Res; 2020 Feb; 39(1):28. PubMed ID: 32019578
[TBL] [Abstract][Full Text] [Related]
7. The radiation response of androgen-refractory prostate cancer cell line C4-2 derived from androgen-sensitive cell line LNCaP.
Xie BX; Zhang H; Yu L; Wang J; Pang B; Wu RQ; Qian XL; Li SH; Shi QG; Wang LL; Zhou JG
Asian J Androl; 2010 May; 12(3):405-14. PubMed ID: 20118949
[TBL] [Abstract][Full Text] [Related]
8. Monitoring Glucocorticoid Receptor in Plasma-derived Extracellular Vesicles as a Marker of Resistance to Androgen Receptor Signaling Inhibition in Prostate Cancer.
Gentile E; Hahn AW; Song JH; Hoang A; Shepherd PDA; Ramachandran S; Navone NM; Efstathiou E; Titus M; Corn PG; Lin SH; Logothetis CJ; Panaretakis T
Cancer Res Commun; 2023 Dec; 3(12):2531-2543. PubMed ID: 37930121
[TBL] [Abstract][Full Text] [Related]
9. Differential targeting of androgen and glucocorticoid receptors induces ER stress and apoptosis in prostate cancer cells: a novel therapeutic modality.
Yemelyanov A; Bhalla P; Yang X; Ugolkov A; Iwadate K; Karseladze A; Budunova I
Cell Cycle; 2012 Jan; 11(2):395-406. PubMed ID: 22223138
[TBL] [Abstract][Full Text] [Related]
10. Endostatin inhibits androgen-independent prostate cancer growth by suppressing nuclear receptor-mediated oxidative stress.
Lee JH; Kang M; Wang H; Naik G; Mobley JA; Sonpavde G; Garvey WT; Darley-Usmar VM; Ponnazhagan S
FASEB J; 2017 Apr; 31(4):1608-1619. PubMed ID: 28069826
[TBL] [Abstract][Full Text] [Related]
11. Enhanced androgen receptor signaling correlates with the androgen-refractory growth in a newly established MDA PCa 2b-hr human prostate cancer cell subline.
Hara T; Nakamura K; Araki H; Kusaka M; Yamaoka M
Cancer Res; 2003 Sep; 63(17):5622-8. PubMed ID: 14500404
[TBL] [Abstract][Full Text] [Related]
12. Relationship between glucocorticoid receptor signal pathway and androgen-independent prostate cancer.
Yan TZ; Jin FS; Xie LP; Li LC
Urol Int; 2008; 81(2):228-33. PubMed ID: 18758226
[TBL] [Abstract][Full Text] [Related]
13. Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines.
Seiler D; Zheng J; Liu G; Wang S; Yamashiro J; Reiter RE; Huang J; Zeng G
Prostate; 2013 Sep; 73(13):1378-90. PubMed ID: 23728788
[TBL] [Abstract][Full Text] [Related]
14. Androgen depletion up-regulates cadherin-11 expression in prostate cancer.
Lee YC; Cheng CJ; Huang M; Bilen MA; Ye X; Navone NM; Chu K; Kao HH; Yu-Lee LY; Wang Z; Lin SH
J Pathol; 2010 May; 221(1):68-76. PubMed ID: 20191612
[TBL] [Abstract][Full Text] [Related]
15. NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice.
Jin RJ; Wang Y; Masumori N; Ishii K; Tsukamoto T; Shappell SB; Hayward SW; Kasper S; Matusik RJ
Cancer Res; 2004 Aug; 64(15):5489-95. PubMed ID: 15289359
[TBL] [Abstract][Full Text] [Related]
16. Preclinical study using androgen receptor (AR) degradation enhancer to increase radiotherapy efficacy via targeting radiation-increased AR to better suppress prostate cancer progression.
Chou FJ; Chen Y; Chen D; Niu Y; Li G; Keng P; Yeh S; Chang C
EBioMedicine; 2019 Feb; 40():504-516. PubMed ID: 30692044
[TBL] [Abstract][Full Text] [Related]
17. βArrestin1 regulates glucocorticoid receptor mitogenic signaling in castration-resistant prostate cancer.
Purayil HT; Daaka Y
Prostate; 2022 May; 82(7):816-825. PubMed ID: 35226379
[TBL] [Abstract][Full Text] [Related]
18. Heme Oxygenase 1 Impairs Glucocorticoid Receptor Activity in Prostate Cancer.
Leonardi DB; Anselmino N; Brandani JN; Jaworski FM; Páez AV; Mazaira G; Meiss RP; Nuñez M; Nemirovsky SI; Giudice J; Galigniana M; Pecci A; Gueron G; Vazquez E; Cotignola J
Int J Mol Sci; 2019 Feb; 20(5):. PubMed ID: 30813528
[TBL] [Abstract][Full Text] [Related]
19. LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis.
Thalmann GN; Sikes RA; Wu TT; Degeorges A; Chang SM; Ozen M; Pathak S; Chung LW
Prostate; 2000 Jul; 44(2):91-103 Jul 1;44(2). PubMed ID: 10881018
[TBL] [Abstract][Full Text] [Related]
20. PAGE4 positivity is associated with attenuated AR signaling and predicts patient survival in hormone-naive prostate cancer.
Sampson N; Ruiz C; Zenzmaier C; Bubendorf L; Berger P
Am J Pathol; 2012 Oct; 181(4):1443-54. PubMed ID: 22885105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]